American Century Companies Inc. Trims Stock Holdings in Ingevity Corporation $NGVT

American Century Companies Inc. lessened its stake in shares of Ingevity Corporation (NYSE:NGVT) by 10.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,535,333 shares of the company’s stock after selling 171,940 shares during the quarter. American Century Companies Inc. owned 4.21% of Ingevity worth $84,735,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. AQR Capital Management LLC lifted its holdings in shares of Ingevity by 10.9% in the 1st quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after acquiring an additional 1,323 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Ingevity by 5.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after purchasing an additional 1,080 shares during the period. Empowered Funds LLC lifted its stake in Ingevity by 12.9% during the first quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock worth $205,000 after purchasing an additional 594 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Ingevity by 311.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after purchasing an additional 454,579 shares in the last quarter. Finally, Jane Street Group LLC boosted its position in shares of Ingevity by 306.1% during the first quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock worth $3,519,000 after buying an additional 66,995 shares during the period. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently issued reports on NGVT. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a report on Thursday, January 22nd. BMO Capital Markets reaffirmed an “outperform” rating and issued a $83.00 target price on shares of Ingevity in a research report on Monday. Wall Street Zen raised shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Sunday. Wells Fargo & Company raised their price objective on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $82.00 target price on shares of Ingevity in a research note on Thursday, February 26th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Ingevity presently has an average rating of “Hold” and a consensus target price of $80.00.

Ingevity Stock Down 1.4%

Shares of NYSE:NGVT opened at $70.66 on Wednesday. Ingevity Corporation has a fifty-two week low of $28.49 and a fifty-two week high of $77.46. The firm’s 50 day moving average price is $67.69 and its 200 day moving average price is $59.42. The company has a quick ratio of 0.79, a current ratio of 1.33 and a debt-to-equity ratio of 39.10. The stock has a market cap of $2.49 billion, a price-to-earnings ratio of -15.20 and a beta of 1.31.

Ingevity (NYSE:NGVT) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.74 by ($0.16). Ingevity had a positive return on equity of 126.25% and a negative net margin of 13.51%.The firm had revenue of $255.10 million for the quarter, compared to analyst estimates of $257.27 million. During the same quarter last year, the firm earned $0.95 EPS. The company’s revenue was down 3.2% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. As a group, equities research analysts predict that Ingevity Corporation will post 4.45 earnings per share for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.